Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(4-Chlorophenyl)-difluoroacetic acid, also known as 4-Cl-PDFA, is a white crystalline solid at room temperature that belongs to the class of difluoroacetic acids. It is insoluble in water and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. Its chemical structure and properties make it a valuable tool for chemical research and drug development, as well as for the preparation of various organic compounds. 4-Cl-PDFA has also been studied for its potential biological activities, including antimicrobial and antioxidant properties.

130754-19-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 130754-19-7 Structure
  • Basic information

    1. Product Name: (4-Chlorophenyl)-difluoroacetic acid
    2. Synonyms: (4-Chlorophenyl)-difluoroacetic acid
    3. CAS NO:130754-19-7
    4. Molecular Formula: C10H9ClF2O2
    5. Molecular Weight: 206.5739064
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 130754-19-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 267.1±35.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.286±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. CAS DataBase Reference: (4-Chlorophenyl)-difluoroacetic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: (4-Chlorophenyl)-difluoroacetic acid(130754-19-7)
    11. EPA Substance Registry System: (4-Chlorophenyl)-difluoroacetic acid(130754-19-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 130754-19-7(Hazardous Substances Data)

130754-19-7 Usage

Uses

Used in Pharmaceutical and Agrochemical Industries:
(4-Chlorophenyl)-difluoroacetic acid is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals for its ability to contribute to the development of new drugs and pesticides.
Used in Organic Compound Preparation:
(4-Chlorophenyl)-difluoroacetic acid is used as a building block in the preparation of various organic compounds, enabling the creation of a wide range of chemical entities for different applications.
Used in Chemical Research:
(4-Chlorophenyl)-difluoroacetic acid is utilized as a valuable tool in chemical research, providing insights into the properties and reactions of difluoroacetic acids and contributing to the advancement of chemical knowledge.
Used in Drug Development:
(4-Chlorophenyl)-difluoroacetic acid is employed in drug development for its potential biological activities, including antimicrobial and antioxidant properties, which may lead to the discovery of new therapeutic agents.
Used in Antimicrobial Applications:
(4-Chlorophenyl)-difluoroacetic acid is used as an antimicrobial agent, leveraging its potential biological activities to combat various microorganisms and contribute to the development of new antimicrobial treatments.
Used in Antioxidant Applications:
(4-Chlorophenyl)-difluoroacetic acid is used as an antioxidant, taking advantage of its potential to neutralize harmful reactive species and protect against oxidative damage in various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 130754-19-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,0,7,5 and 4 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 130754-19:
(8*1)+(7*3)+(6*0)+(5*7)+(4*5)+(3*4)+(2*1)+(1*9)=107
107 % 10 = 7
So 130754-19-7 is a valid CAS Registry Number.

130754-19-7Relevant articles and documents

A convenient synthetic approach to a novel class of aryldifluoromethyl pyrimidine derivatives containing strobilurin motif as insecticidal agents

Hao, Shulin,Cai, Zengfei,Zhang, Wenliang,Cao, Yangyang,Du, Xiaohua

, p. 88 - 96 (2021/10/07)

A series of aryldifluoromethyl pyrimidine compounds containing strobilurin were synthesized through bioelectronic isometric design with azoxystrobin as the lead compound and a convenient approach to aryldifluoromethylpyrimidine intermediates was developed, which features mild reaction conditions and simple operation. The title compounds and aryldifluoromethylpyrimidine intermediates were characterized by NMR and HRMS. Both 7c and 7l of the preliminary screening tests showed 100% inhibition against Mythimna separata at 100 mg/L. At 20 mg/L, the lethal rate of 7l against Mythimna separata can be up to 80%.

Silver-catalyzed decarboxylative radical allylation of α,α-difluoroarylacetic acids for the construction of CF2-allyl bonds

Wang, Pingyang,Du, Pengcheng,Sun, Qianqian,Zhang, Jianhua,Deng, Hongmei,Jiang, Haizhen

supporting information, p. 2023 - 2029 (2021/03/16)

An efficient silver-catalyzed method of decarboxylative radical allylation of α,α-difluoroarylacetic acids to build CF2-allyl bonds has been developed. Using allylsulfone as an allyl donor, α,α-difluorine substituted arylacetic acids bearing various functional groups are successfully allylated to access a series of 3-(α,α-difluorobenzyl)-1-propylene compounds in moderate to excellent yields in aqueous CH3CN solution under the mild conditions. Experimental studies disclosed that the α-fluorine substitution of arylacetic acid has a great influence on free radical activity and reactivity.

Direct Approach to 3-Fluoroindoles and 3,3-Difluoroindolines from 2,2-Difluoro-2-phenylethan-1-amines via C-H/N-H Coupling

Zhang, Lanfei,Zhang, Xiaofei,Cui, Yongmei,Yang, Chunhao

supporting information, p. 3815 - 3826 (2021/06/28)

Herein, a direct method for the synthesis of 3-fluoroindoles and 3,3-difluoroindolines from easily accessible 2,2-difluoro-2-phenyl ethan-1-amines is presented. This protocol was performed by Pd-catalyzed direct C-H/N-H coupling and employed picolinamide as a directing group. By controlling the temperature for this transformation, various 3,3-difluoroindolines and 3-fluoroindoles could be isolated with moderate to good yields.

Generation of Axially Chiral Fluoroallenes through a Copper-Catalyzed Enantioselective β-Fluoride Elimination

Liu, Peng,Mai, Binh Khanh,Nafie, Jordan,O'Connor, Thomas J.,Toste, F. Dean

supporting information, p. 13759 - 13768 (2021/09/07)

Herein we report the copper-catalyzed silylation of propargylic difluorides to generate axially chiral, tetrasubstituted monofluoroallenes in both good yields (27 examples >80%) and enantioselectivities (82-98% ee). Compared to previously reported synthetic routes to axially chiral allenes (ACAs) from prochiral substrates, a mechanistically distinct reaction has been developed: the enantiodiscrimination between enantiotopic fluorides to set an axial stereocenter. DFT calculations and vibrational circular dichroism (VCD) suggest that β-fluoride elimination from an alkenyl copper intermediate likely proceeds through a syn-β-fluoride elimination pathway rather than an anti-elimination pathway. The effects of the C1-symmetric Josiphos-derived ligand on reactivity and enantioselectivity were investigated. Not only does this report showcase that alkenyl copper species (like their alkyl counterparts) can undergo β-fluoride elimination, but this elimination can be achieved in an enantioselective fashion.

COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS

-

Page/Page column 71, (2020/08/22)

The invention relates to a compound of Formula I, pharmaceutical compositions comprising a compound of Formula I, and pharmaceutically acceptable slats thereof, pharmaceutical compositions comprising such compounds and methods of treating cystic fibrosis comprising the step of administering a therapeutically effective amount of a compound of Formula I to a subject in need thereof.

Synthetic method of aromatic ring group or aromatic heterocyclic tetrazole

-

Paragraph 0036-0042; 0046, (2020/12/30)

The synthetic method comprises the following steps: (1) reacting 1.0 eq of ArI or HArI with 1.2 eq of ethyl 2, 2-difluoroacetate in the presence of DMSO as a solvent and 4.0 eq of Cu under the protection of nitrogen at 30 DEG C and 50 DEG C, and purifying to obtain a first intermediate compound; (2) dissolving 1.0 eq of the first intermediate compound in a mixed solvent of THF and water, adding 2.0 eq of LiOH, reacting at room temperature for 2 hours, spin-drying the solvent, adding HCl until the pH value is equal to 3, and filtering to obtain a second intermediate compound; and (3) reacting 1.0 eq of the second intermediate compound with 2.0 eq of diphenyl azide phosphate in the presence of 2.5 eq of triethylamine by taking tert-butyl alcohol as a solvent to generate aromatic ring group or aromatic heterocyclic tetrazole. The invention provides a novel synthetic method of aromatic ring group or aromatic heterocyclic tetrazole, wherein a target compound can be more conveniently obtained, and reagents participating in the reaction are low in toxicity, mild in reaction condition, simple and safe in aftertreatment, good in product quality and suitable for large-scale production.

Substituted amide phenol compound and its preparation method, pharmaceutical composition and use thereof

-

Paragraph 0355-0358, (2019/07/04)

The invention discloses substituted-amide phenolic compounds, their preparation method, a pharmaceutical composition and an application thereof. The compounds have a structure as shown in the general formula I, wherein Z, L and Q are as defined in the spe

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

-

Paragraph 00234; 00235; 00240, (2018/07/29)

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

Synthesis, Characterization, and Reactivity of Palladium Fluoroenolate Complexes

Arlow, Sophie I.,Hartwig, John F.

supporting information, p. 16088 - 16091 (2017/11/22)

Cross-coupling reactions of aryl groups with α-fluoro carbonyl compounds catalyzed by palladium complexes have been reported, but palladium fluoroenolate intermediates relevant to such reactions have not been isolated or even detected previously. We report the synthesis, structural characterization, and reactivity of a series of C-bound arylpalladium fluoroenolate complexes ligated by monophosphines and bisphosphines. DPPF-ligated arylpalladium fluoroenolate complexes (DPPF = 1,1-bis(diphenylphosphino)-ferrocene) derived from a monofluoroester, a difluoroester, difluoroamides, and difluoroacetonitrile underwent reductive elimination in high yields. Reductive elimination was faster from complexes containing less electron-withdrawing fluoroenolate groups and longer Pd-C(enolate) bonds than from complexes containing more electron-withdrawing fluoroenolate groups and shorter Pd-C(enolate) bonds. The rates of reductive elimination from these C-bound fluoroenolate complexes were significantly faster than those of the analogous trifluoromethyl complexes.

Easy Access to Difluoromethylene-Containing Arene Analogues through Palladium-Catalysed C–H Olefination

Shao, Changdong,Shi, Guangfa,Zhang, Yanghui

, p. 5529 - 5538 (2016/11/25)

An efficient palladium-catalysed ortho-C–H olefination of α,α-difluorophenylacetic acid derivatives using 8-aminoquinoline as a bidentate directing group has been developed. A range of olefinated arenes can thus be synthesized in a concise way. This reaction provides an easy and straightforward route to a panel of difluoromethylated arene analogues in moderate to good yields, with a satisfactory tolerance of common functional groups. Transformation of the products into a variety of other difluoromethylene-containing compounds demonstrates the utility of this method.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 130754-19-7